The Oncology Pharmacy Post-Graduate Year 2 (PGY2) Residency at Baptist Hospital of Miami and the Miami Cancer Institute is a 12-month training program accredited by the American Society of Health System Pharmacists (ASHP). The purpose of the program is to develop well-rounded oncology pharmacy practitioners and effective clinical instructors capable of providing a high-level patient care and clinical instruction to pharmacy and medical trainees.
The program provides residents with experience in adult medical oncology, malignant hematology, bone marrow transplant and cellular therapy, pediatric hematology and oncology, and investigational drug services in acute and ambulatory care settings. The training is coordinated to ensure the resident masters each of the disease states established within the ASHP Practice Standards for PGY2 oncology programs. Residents will develop skills in designing and monitoring evidence-based therapeutic regimens for individuals with cancer to ensure optimal outcomes while minimizing adverse drug events. In addition, the resident will develop skills in leadership, research, and teaching through projects, drug information, education and precepting PGY1 residents and pharmacy students.
The Miami Cancer Institute Pharmacy Team was awarded the 2022 Warren E. Weaver/Richard P. Penna Award by the Board of Pharmacy Specialties (BPS) recognized for the organization's commitment to advancing health equity and patient care. The department has over 30 board-certified pharmacists, several of whom carry dual board certification, and residency preceptors within all specialized practice environments in oncology including breast, lung, head and neck, skin, genitourinary, gastrointestinal, gynecologic cancers, neuro oncology, hematology, bone marrow transplant, and cellular therapy, investigational drug therapies, and pediatric hematology and oncology.
After successful completion of this program, the graduating resident will have the necessary knowledge and skills in order to achieve board certification in oncology and demonstrate clinical and leadership abilities to perform as an oncology clinical specialist.
American Society of Health-System Pharmacists (ASHP) | ID: 33047
Miami Cancer Institute
The Miami Cancer Institute, located on the campus of Baptist Hospital, is a destination cancer center known for its innovation and precision in cancer care, exceptional patient experience, advanced clinical research and state-of-the-art technology. The impressive roster of clinicians at Miami Cancer Institute includes renowned oncologists; world-recognized, highly sub-specialized cancer experts and surgeons; clinical researchers and genomic scientists. The Center’s advanced radiation oncology program includes the first proton therapy center from South Florida to South America. As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments close to home and ensures that the standards of care developed by the multidisciplinary disease management teams match those at MSK. Miami Cancer Institute received awards in leukemia, lymphoma, and myeloma as well as surgery in lung, prostate, and colon cancers in 2023-2024 U.S. News & World Report Best Hospital Rankings.
The flagship facility of Baptist Health South Florida, Baptist Hospital of Miami has been one of the most respected medical centers in South Florida since its founding in 1960 and is today one of America’s most preferred medical centers. With more than 900 beds, it is the largest of Baptist Health’s 12 hospitals. Three Centers of Excellence are housed on the campus: Miami Cancer Institute, Miami Cardiac & Vascular Institute (the largest and most comprehensive cardiovascular facility in the region) and Miami Neuroscience Institute. Baptist Hospital has earned Magnet Recognition for nursing excellence. It is also certified as a Comprehensive Stroke Center by The Joint Commission and received the Gold Seal of Approval for consistently meeting high national standards of stroke care. Baptist Hospital was ranked #1 in the Miami-Fort Lauderdale metro area for the 2023-2024 U.S. News and World Report Best Hospitals Ranking.
- Pharm.D. degree from an ACPE accredited college of pharmacy
- Completion of an ASHP accredited PGY-1 pharmacy residency (certificate required)
- Must obtain a Florida pharmacist’s license
Prospective residents are required to submit the following:
- Curriculum Vitae
- Official transcripts from all colleges of pharmacy attended
- Three letters of recommendation from professional references utilizing standard form required by PhORCAS™
- Personal statement of intent
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.
- Where do applicants go to apply? Pharmacy Online Residency Centralized Application Service (PhORCAS™).
- When are applications accepted? November to January
- When are candidate interviews? January and February
When are candidates matched/notified of acceptance?
ASHP Resident Matching Program – National Matching Services, Inc.
National Matching Service Code: 682860
- When does the program start? July 1st
Oncology Pharmacy Practice
- Committee Participation including Oncology Pharmacy & Therapeutics
- Drug Monograph/Class Review/Regimen Review
- Drug Information
- Newsletter Publication
- Chief Resident